TP53 and lung carcinoma: Meanwhile, the TP53 p.R282G and p.Y234H have not been reported to be present in the ICGC’s serous ovarian carcinoma cases but have been detected in lung cancer (0.9%), breast cancer (0.11%) and renal cancer (0.25%) [20].